Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Charles & Colvard ( (CTHR) ) is now available.
On June 24, 2025, Charles & Colvard entered into a Convertible Secured Note Purchase Agreement with Ethara Capital LLC, resulting in a $2.0 million investment issued in two tranches, with the final closing on July 21, 2025. Additionally, the company announced changes to its board of directors, including the resignation of Ollin Sykes and the appointment of Ruten Bhanderi and James Tu, with Mr. Tu becoming the new Chairman. These changes are part of the company’s strategic alignment with Ethara Capital’s interests, potentially impacting its governance and operational strategies.
Spark’s Take on CTHR Stock
According to Spark, TipRanks’ AI Analyst, CTHR is a Neutral.
Charles & Colvard’s stock is significantly impacted by poor financial performance and valuation metrics, which are compounded by technical indicators signaling a bearish trend. While the convertible note agreement is a positive step, the Nasdaq delisting raises serious concerns about the company’s future trading prospects.
To see Spark’s full report on CTHR stock, click here.
More about Charles & Colvard
Charles & Colvard, Ltd. operates in the jewelry industry, focusing on the production and sale of lab-grown diamonds and moissanite gemstones.
Average Trading Volume: 5,987
Technical Sentiment Signal: Sell
Current Market Cap: $935.5K
For detailed information about CTHR stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money